-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D9qfvQp4/V3zPnsNpFH3mJxSI22JZ9m+CNMlDiK7RcmtA6Zty3lSNG/Yc8knRIdW pJqMSNrnp0NLwHWIMuumWQ== 0001225208-10-021219.txt : 20100922 0001225208-10-021219.hdr.sgml : 20100922 20100922114509 ACCESSION NUMBER: 0001225208-10-021219 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100916 FILED AS OF DATE: 20100922 DATE AS OF CHANGE: 20100922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heerdt Kari D CENTRAL INDEX KEY: 0001472094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34473 FILM NUMBER: 101084150 MAIL ADDRESS: STREET 1: 79 TW ALEXANDER DRIVE STREET 2: 4101 RESEARCH COMMONS CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Talecris Biotherapeutics Holdings Corp. CENTRAL INDEX KEY: 0001405197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202533768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4101 RESEARCH COMMONS STREET 2: 79 T.W. ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-316-6300 MAIL ADDRESS: STREET 1: P.O. BOX 110526 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 doc4.xml X0303 4 2010-09-16 0001405197 Talecris Biotherapeutics Holdings Corp. TLCR 0001472094 Heerdt Kari D 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 1 Sr. VP, Human Resources Common Stock 2010-09-16 4 M 0 108000.0000 11.0000 A 111947.0000 D Common Stock 2010-09-16 4 S 0 108000.0000 23.0605 D 3947.0000 D Options (right to buy) 11.0000 2010-09-16 4 M 0 108000.0000 11.0000 D 2009-04-01 2018-04-01 Common Stock 108000.0000 108000.0000 D The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010. The number of shares reported includes restricted share units representing the right to receive 3,947 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.99 to $23.095, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The option is fully vested and immediately exercisable. /s/ John F. Gaither Jr., attorney in fact 2010-09-22 -----END PRIVACY-ENHANCED MESSAGE-----